NCT06954441
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
- Locations
-
- IMIP Centro de Pesquisa Recife, Pernanbuco, Brazil
Clinical trial condition
Agammaglobulinemia
Explore clinical trials studying Agammaglobulinemia. Study availability and eligibility vary by location and protocol.
9 public trials
1 recruiting study
Agammaglobulinemia trial results
NCT00161993
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Tampere University Hospital Tampere, Finland
- Turku University Central Hospital Turku, Finland
- SU/Sahlgrenska Gothenburg, Sweden
- University Hospital Lund Lund, Sweden
Completed
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
NCT01581593
- Conditions
- Agammaglobulinemia, Antibody Deficiency, Blood Protein Disorders, +11 more
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
- Rush University Chicago, Illinois, United States
Completed
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
NCT00520494
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
- Locations
-
- Contact CSL Behring for facility details Edmonton, Alberta, Canada
- Contact CSL Behring for facility details Montreal, Quebec, Canada
- Contact CSL Behring for facility details Leipzig, Germany
- Contact CSL Behring for facility details Brescia, Italy
NCT00322556
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +8 more
- Locations
-
- Contact CSL Behring for facility details Los Angeles, California, United States
- Contact CSL Behring for facility details Centennial, Colorado, United States
- Contact CSL Behring for facility details North Palm Beach, Florida, United States
- Contact CSL Behring for facility details St. Petersburg, Florida, United States
NCT00168025
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +8 more
- Locations
-
Not specified
NCT00168012
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +8 more
- Locations
-
Not specified
Completed
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
NCT00220766
- Conditions
- Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +24 more
- Locations
-
- Departments of Medicine and Microbiology Birmingham, Alabama, United States
- National Jewish Medical and Researach Center Denver, Colorado, United States
- International Center for Interdisciplinary Studies of Immunology Washington D.C., District of Columbia, United States
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
NCT00661401
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Common Variable Immunodeficiency, +9 more
- Locations
-
- Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo São Paulo, Brazil